Targeting the PI3K pathway in cancer: are we making headway?
Filip Jankú, Timothy A. Yap, Funda Meric‐Bernstam
Topics & Concepts
PI3K/AKT/mTOR pathwayMedicineTemsirolimusIdelalisibEverolimusClinical trialCancerProtein kinase BPharmacologyCancer researchOncologyBioinformaticsDiscovery and development of mTOR inhibitorsInternal medicineSignal transductionBiologyIbrutinibBiochemistryChronic lymphocytic leukemiaLeukemiaPI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and MutationsAdvanced Breast Cancer Therapies